143 related articles for article (PubMed ID: 19555714)
1. Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges.
Frasch CE
Vaccine; 2009 Oct; 27(46):6468-70. PubMed ID: 19555714
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
3. Parameters underlying distinct T cell-dependent polysaccharide-specific IgG responses to an intact gram-positive bacterium versus a soluble conjugate vaccine.
Colino J; Chattopadhyay G; Sen G; Chen Q; Lees A; Canaday DH; Rubtsov A; Torres R; Snapper CM
J Immunol; 2009 Aug; 183(3):1551-9. PubMed ID: 19570830
[TBL] [Abstract][Full Text] [Related]
4. Characterization of saccharide-CRM197 conjugate vaccines.
Hsieh CL
Dev Biol (Basel); 2000; 103():93-104. PubMed ID: 11214258
[TBL] [Abstract][Full Text] [Related]
5. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide.
Csordas FC; Perciani CT; Darrieux M; Gonçalves VM; Cabrera-Crespo J; Takagi M; Sbrogio-Almeida ME; Leite LC; Tanizaki MM
Vaccine; 2008 Jun; 26(23):2925-9. PubMed ID: 18440673
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the conjugation method for a serogroup B/C meningococcal vaccine.
Fukasawa LO; Schenkman RP; Perciani CT; Carneiro SM; Dias WO; Tanizaki MM
Biotechnol Appl Biochem; 2006 Nov; 45(Pt 3):141-6. PubMed ID: 16776648
[TBL] [Abstract][Full Text] [Related]
7. Improved methods for the quantification of free and linked spacer in conjugate vaccine process.
Adam O; Moreau M
Dev Biol (Basel); 2000; 103():105-11. PubMed ID: 11214228
[TBL] [Abstract][Full Text] [Related]
8. TEMPO-mediated glycoconjugation: a scheme for the controlled synthesis of polysaccharide conjugates.
Ma Z; Bertolo L; Arar S; Monteiro MA
Carbohydr Res; 2011 Feb; 346(2):343-7. PubMed ID: 21167478
[TBL] [Abstract][Full Text] [Related]
9. Improved conjugation and purification strategies for the preparation of protein-polysaccharide conjugates.
Suárez N; Massaldi H; Franco Fraguas L; Ferreira F
J Chromatogr A; 2008 Dec; 1213(2):169-75. PubMed ID: 18992885
[TBL] [Abstract][Full Text] [Related]
10. Monitoring activation sites on polysaccharides by GC-MS.
Kim JS; Laskowich ER; Michon F; Kaiser RE; Arumugham RG
Anal Biochem; 2006 Nov; 358(1):136-42. PubMed ID: 16979576
[TBL] [Abstract][Full Text] [Related]
11. NMR assays for carbohydrate-based vaccines.
Jones C
J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
[TBL] [Abstract][Full Text] [Related]
12. Characterization and quantification of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharide preparations.
Xu Q; Abeygunawardana C; Ng AS; Sturgess AW; Harmon BJ; Hennessey JP
Anal Biochem; 2005 Jan; 336(2):262-72. PubMed ID: 15620891
[TBL] [Abstract][Full Text] [Related]
13. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
Pulickal AS; Pollard AJ
Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
[No Abstract] [Full Text] [Related]
14. A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines.
Pawlowski A; Källenius G; Svenson SB
Vaccine; 1999 Mar; 17(11-12):1474-83. PubMed ID: 10195784
[TBL] [Abstract][Full Text] [Related]
15. Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry.
Lees A; Sen G; LopezAcosta A
Vaccine; 2006 Feb; 24(6):716-29. PubMed ID: 16233938
[TBL] [Abstract][Full Text] [Related]
16. Innovative vaccine production technologies: the evolution and value of vaccine production technologies.
Bae K; Choi J; Jang Y; Ahn S; Hur B
Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Production of Shigella flexneri Polysaccharide from a Newly Devised Silicate Method as a Potential Vaccine Conjugate.
Narayana PVSLSS; Ray Dutta J
Curr Microbiol; 2019 Dec; 76(12):1398-1406. PubMed ID: 31583437
[TBL] [Abstract][Full Text] [Related]
18. High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines.
Noyes A; Huffman B; Berrill A; Merchant N; Godavarti R; Titchener-Hooker N; Coffman J; Sunasara K; Mukhopadhyay T
Biotechnol Bioeng; 2015 Aug; 112(8):1568-82. PubMed ID: 25727194
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the rkp-3 gene region in Sinorhizobium meliloti 41: rkpY directs capsular polysaccharide synthesis to KR5 antigen production.
Pálvölgyi A; Deák V; Poinsot V; Nagy T; Nagy E; Kerepesi I; Putnoky P
Mol Plant Microbe Interact; 2009 Nov; 22(11):1422-30. PubMed ID: 19810811
[TBL] [Abstract][Full Text] [Related]
20. On the preparation of carbohydrate-protein conjugates using the traceless Staudinger ligation.
Grandjean C; Boutonnier A; Guerreiro C; Fournier JM; Mulard LA
J Org Chem; 2005 Sep; 70(18):7123-32. PubMed ID: 16122231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
